Hematopoietic Recovery According to CD34+Cell Count Reinfused
| Parameters . | All Patients (n = 168) . | CD34+ Cell Dose (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 (n = 22) . | >2.5 and <15 (n = 105) . | ≥15 (n = 41) . | ||
| Median days to ANC >0.1 × 109/L (range) | 10 (5-18) | 11* (9-18) | 10 (5-13) | 9* (7-13) |
| 10th/90th percentile (d) | 9/12 | 10/14 | 9/11 | 9/11 |
| Median days to ANC >0.5 × 109/L (range) | 11 (6-22) | 12* (10-22) | 11 (6-14) | 10* (7-15) |
| 10th/90th percentile (d) | 10/13 | 11/17 | 10/13 | 9/12 |
| Median days to ANC >1.0 × 109/L (range) | 12 (7-27) | 13* (10-27) | 12 (7-17) | 11* (8-16) |
| 10th/90th percentile (d) | 10/14 | 11/21 | 10/14 | 10/12 |
| Median days to PLT >20 × 109/L (range) | 10 (6-180+) | 14* (7-180+) | 10 (6-24) | 8* (6-13) |
| 10th/90th percentile (d) | 7/14 | 9/97 | 8/13 | 7/9 |
| Median days to PLT >50 × 109/L (range) | 14 (7-180+) | 19* (11-180+) | 14 (8-180+) | 11* (7-24) |
| 10th/90th percentile (d) | 10/21 | 13/121 | 11/18 | 9/14 |
| Median days to PLT >100 × 109/L (range) | 17 (9-180+) | 61* (15-180+) | 17 (11-180+) | 14* (9-180+) |
| 10th/90th percentile (d) | 13/58 | 15/180+ | 14/27 | 11/18 |
| Parameters . | All Patients (n = 168) . | CD34+ Cell Dose (×106/kg) . | ||
|---|---|---|---|---|
| ≤2.5 (n = 22) . | >2.5 and <15 (n = 105) . | ≥15 (n = 41) . | ||
| Median days to ANC >0.1 × 109/L (range) | 10 (5-18) | 11* (9-18) | 10 (5-13) | 9* (7-13) |
| 10th/90th percentile (d) | 9/12 | 10/14 | 9/11 | 9/11 |
| Median days to ANC >0.5 × 109/L (range) | 11 (6-22) | 12* (10-22) | 11 (6-14) | 10* (7-15) |
| 10th/90th percentile (d) | 10/13 | 11/17 | 10/13 | 9/12 |
| Median days to ANC >1.0 × 109/L (range) | 12 (7-27) | 13* (10-27) | 12 (7-17) | 11* (8-16) |
| 10th/90th percentile (d) | 10/14 | 11/21 | 10/14 | 10/12 |
| Median days to PLT >20 × 109/L (range) | 10 (6-180+) | 14* (7-180+) | 10 (6-24) | 8* (6-13) |
| 10th/90th percentile (d) | 7/14 | 9/97 | 8/13 | 7/9 |
| Median days to PLT >50 × 109/L (range) | 14 (7-180+) | 19* (11-180+) | 14 (8-180+) | 11* (7-24) |
| 10th/90th percentile (d) | 10/21 | 13/121 | 11/18 | 9/14 |
| Median days to PLT >100 × 109/L (range) | 17 (9-180+) | 61* (15-180+) | 17 (11-180+) | 14* (9-180+) |
| 10th/90th percentile (d) | 13/58 | 15/180+ | 14/27 | 11/18 |
Abbreviations: ANC, absolute neutrophil count; PLT, platelets.
P < .05 compared with the intermediate CD34+group using the log-rank test. Only P < .05 was considered as significant.